Analyzing...
Loading company...
Nothing flagged for monitoring
“Services business in Healthcare — Hospitals & Diagnostics.”
₹4,138 Cr service revenue.
Employee costs at 18.4% of revenue — primary cost driver.
“Plus the synergy element that we have guided that, you know, we expect 10 to 15% of EBITDA coming in form of synergies over the next two to three years.”
“mature units, which is approximately 60% of our revenue, delivered a 12.”
“revenue increased 19% year on year to 619 crores, highlighting the sustained strength of the core hospitals and the ability to grow on a elevated base established earlier in the year.”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 7.2%▼ | 7.9% |
| ROCE | 9.6%▼ | 11.3% |
| Net Margin | 7.1%▼ | 9.3% |
| EBITDA Margin | 20.1%▼ | 21.9% |
| Debt To Equity | 0.14x▼ | 0.16x |
| Rev Growth 3yr | -25.4%▼ | 12.4% |
| EPS Growth 3yr | 117.0%▲ | 11.8% |
| Employee Cost Ratio | 18.40x | - |
Historical valuation data not available.
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹4,461 Cr +7.8% | ₹4,138 Cr +11.9% | ₹3,699 Cr -69.0% | ₹11,933 Cr +16.4% | ₹10,253 Cr +19.1% | ₹8,608 Cr -1.5% | ₹8,739 Cr +9.7% | ₹7,963 Cr |
| Other Income | ₹121 Cr -18.6% | ₹148 Cr +496.5% | ₹25 Cr -68.2% | ₹78 Cr +54.5% | ₹51 Cr +1.4% | ₹50 Cr +32.0% | ₹38 Cr +9.4% | ₹35 Cr |
| Total Income | ₹4,582 Cr +6.9% | ₹4,287 Cr +15.1% | ₹3,724 Cr -69.0% | ₹12,011 Cr +16.6% | ₹10,304 Cr +19.0% | ₹8,658 Cr -1.3% | ₹8,776 Cr +9.7% | ₹7,997 Cr |
| COGS | ₹1,011 Cr +7.7% | ₹938 Cr +2.5% | ₹916 Cr -74.1% | ₹3,532 Cr +22.1% | ₹2,892 Cr +13.5% | ₹2,549 Cr -3.3% | ₹2,635 Cr +8.9% | ₹2,420 Cr |
| ₹3,987 Cr +6.4% | ₹3,747 Cr +8.6% | ₹3,451 Cr -69.9% | ₹11,477 Cr +18.7% | ₹9,668 Cr +14.3% | ₹8,457 Cr +0.4% | ₹8,427 Cr +11.1% | ₹7,585 Cr | |
| Profit Before Tax | ₹535 Cr +9.3% | ₹490 Cr +79.8% | ₹273 Cr -49.0% | ₹534 Cr -16.1% | ₹636 Cr +215.7% | ₹202 Cr -39.0% | ₹330 Cr -19.6% | ₹411 Cr |
| Exceptional Items | (₹59 Cr) -18.6% | (₹50 Cr) | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr +100.0% | (₹20 Cr) | (₹2 Cr) |
| ₹138 Cr +2.6% | ₹134 Cr +137.8% | ₹57 Cr -5.2% | ₹60 Cr +66.5% | ₹36 Cr +31.5% | ₹27 Cr +77.0% | ₹15 Cr -64.2% | ₹43 Cr | |
| Net Profit | ₹359 Cr -93.4% | ₹5,408 Cr | ₹212 Cr -55.5% | ₹475 Cr -20.9% | ₹601 Cr +238.0% | ₹178 Cr -43.5% | ₹315 Cr -14.3% | ₹367 Cr |
| Profit (Owners) | ₹327 Cr -93.9% | ₹5,378 Cr | ₹129 Cr -69.6% | ₹425 Cr -19.2% | ₹526 Cr +256.0% | ₹148 Cr -46.6% | ₹277 Cr -17.0% | ₹333 Cr |
| Minority Interest | ₹32 Cr +6.7% | ₹30 Cr -63.5% | ₹82 Cr +62.7% | ₹51 Cr -32.6% | ₹75 Cr +149.5% | ₹30 Cr -20.9% | ₹38 Cr +11.3% | ₹34 Cr |
| Other Comprehensive Income | (₹4 Cr) -100.5% | (₹2 Cr) ↓ Decline | ₹46 Cr -76.7% | ₹199 Cr +112.9% | ₹93 Cr ↑ Recovery | (₹50 Cr) ↓ Decline | ₹145 Cr +131.7% | ₹62 Cr |
| EPS | ₹6.36 | ₹107.66 | ₹2.59 | ₹8.51 | ₹10.53 | ₹2.96 | ₹5.54 | ₹6.59 |
| Diluted Shares | ₹52 Cr | ₹50 Cr | ₹50 Cr | ₹50 Cr | ₹50 Cr | ₹50 Cr | ₹50 Cr | ₹51 Cr |
| Profit Or Loss Of Associates | (₹38 Cr) -103.5% | (₹19 Cr) -66.8% | (₹11 Cr) ↓ Decline | ₹1 Cr +125.9% | ₹0.54 Cr -84.7% | ₹4 Cr ↑ Recovery | (₹0.19 Cr) +24.0% | (₹0.25 Cr) |
| Profit Loss From Discontinued Operations After Tax | ₹0.00 Cr -100.0% | ₹5,071 Cr | ₹7 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
Aster DM Healthcare Limited has informed the Exchange about Investor Presentation
Aster DM Healthcare Limited has informed the Exchange about Schedule of meet
Dr. Mandayapurath Azad Moopen has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) ...
Dr. Mandayapurath Azad Moopen has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) ...
Aster DM Healthcare Limited has informed the Exchange about Transcript
Aster DM Healthcare Limited has informed the Exchange about Copy of Newspaper Publication regarding audited financial results of the Company for the quarter and year ended March 31, 2026.
Aster DM Healthcare Limited has informed the Exchange regarding a press release dated April 30, 2026, titled "Aster DM Healthcare Q4 FY26 Results".
Aster DM Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Aster DM Healthcare Limited has informed the Exchange about General Updates
Aster DM Healthcare Limited has informed the Exchange that Record date for the purpose of Dividend is 03-Apr-2026.
Aster DM Healthcare Limited has informed the Exchange that Board of Directors at its meeting held on March 26, 2026, declared Interim Dividend of Rs. 3 per equity share.
Aster DM Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Aster DM Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
Aster DM Healthcare Limited has informed the Exchange about strikes/lockouts/disturbances
Aster DM Healthcare Limited has informed the Exchange about General Updates